Kyle Dempsey

[Kyle Dempsey @kyleedempsey3]

@EricTopol @ASCO Also worth mentioning the metastatic brain cancer curves from this phase III study— the magnitude of OS improvement is unprecedented, and it’s been >20 years since any study has shown as OS benefit!

[Hussein Tawbi, MD, PhD @HTawbi_MDPhD]

Oral presentation #ASCO26, @DrJeffWeinberg shares results of GammaTile vs post-op SRS for patients undergoing resection for Brain metastases. Tour de force Phase 3 study superior time to surgical bed recurrence (HR 0.06, p=0.0069) & impressively improved overall survival (HR 0.59, p=0.032)

[Mohamed A. El-Erian @elerianm]

Powered by @Apple looking to build on yesterday's impressive 6% rise, NASDAQ Futures point to solid gains at the open.

With the lack of new information this week, analysts are again searching for a narrative to explain this market action--a causation reversal that's intensifying